| Financial Year |
March 31 2023 |
| Monetary Funds |
1,311,973,758.18 |
| Held-for-trading Financial Assets |
33,641,574.45 |
| Notes Receivable |
103,048,794.89 |
| Accounts Receivable |
498,617,418.07 |
| Advances to Suppliers |
5,234,543.00 |
| Other Receivables |
22,961,887.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
17,047,671.23 |
| Dividend Receivable |
-- |
| Inventories |
218,278,910.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,048,946.23 |
| Total Current Assets |
2,398,316,958.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,629,505.24 |
| Investment Properties |
-- |
| Fixed Assetes |
392,986,942.31 |
| Under-construction Projects |
599,900,629.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,066,259.25 |
| R&D expenses |
-- |
| Goodwill |
5,820,054.87 |
| Long-Term Deferred and Prepaid Expenses |
9,780,159.97 |
| Deferred Income Tax Assets |
15,068,971.59 |
| Other Non-Current Assets |
135,376,095.10 |
| Sub-Total of Non-Current Assets |
1,263,744,474.24 |
| Total Assets |
3,662,061,432.45 |
| Short-Term Loans |
24,235,910.83 |
| Trading Financial liabilities |
10,205,077.86 |
| Notes Payable |
96,749,093.40 |
| Accounts Payable |
185,861,616.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,589,257.19 |
| Taxes Payable |
9,592,661.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
148,236,559.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,727,332.82 |
| Other Current Liabilities |
5,041,410.68 |
| Sub-Total of Current Liabilities |
511,693,485.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,355,058.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
47,374,089.43 |
| Total Liabilities |
559,067,575.25 |
| Paid-In Capital(Or Share Stock) |
233,600,000.00 |
| Capital Surplus |
2,360,135,751.07 |
| Surplus Reserve |
47,719,195.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
460,117,159.33 |
| Minority Stockholder's Interest |
5,159,351.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,097,834,505.55 |
| Owner's Equity（Stockholder's Equity） |
3,102,993,857.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,662,061,432.45 |
